Expression of a dominant-negative mutant form of caspase-1 in R6/2 mice extended survival and delayed the appearance of neuronal inclusions, receptor alterations and the onset of symptoms [72], and was associated with increased resistance to the neurotoxins used to model HD [80]. Here, CASP1 is linked to Huntington disease.